NDC properties for "lenalidomide 5 MG Oral Capsule" (RxCUI 602912)
About this data
The tables show NDC propoerties for lenalidomide 5 MG Oral Capsule with the RxCUI 602912
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 5 MG Oral Capsule (RxCUI 602912)
| ANDA | ANDA201452 |
|---|---|
| ANDA | ANDA209348 |
| ANDA | ANDA210154 |
| ANDA | ANDA210435 |
| ANDA | ANDA210480 |
| ANDA | ANDA211022 |
| ANDA | ANDA211846 |
| ANDA | ANDA212414 |
| ANDA | ANDA213885 |
| ANDA | ANDA213912 |
| MMSL_CODE | BD15733 |
| MMSL_CODE | CD15733 |
| RxCUI | 602912 |
| SNOMEDCT | 422330004 |
| SPL_SET_ID | 1b2716cf-24b4-4157-a218-58ede63917bd |
| SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
| SPL_SET_ID | 682e8a86-9f49-45db-a2ea-403ee1dc62d2 |
| SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
| SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
| SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
| SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
| SPL_SET_ID | ba2a07fd-ca60-40bc-b79b-9caf81900fa3 |
| SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
| SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
| SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
| SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
| VUID | 4025035 |
| Prescribable Synonym | lenalidomide 5 MG Oral Capsule |
| RXNAV_STR | lenalidomide 5 MG Oral Capsule |
| RxNorm Name | lenalidomide 5 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 602912) |
NDC Properties
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |
NDC Item 00378193601
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-01 |
| NDC Item | 00378193601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00378193628
| NDC 9 | 0378-1936 |
|---|---|
| NDC 10 | 0378-1936-28 |
| NDC Item | 00378193628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;5 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0378-1936 |
NDC Item 00480124228
| NDC 9 | 0480-1242 |
|---|---|
| NDC 10 | 0480-1242-28 |
| NDC Item | 00480124228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;5mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1242 |
NDC Item 31722025801
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-01 |
| NDC Item | 31722025801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 31722025828
| NDC 9 | 31722-258 |
|---|---|
| NDC 10 | 31722-258-28 |
| NDC Item | 31722025828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L2 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 31722-258 |
NDC Item 43598051101
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-01 |
| NDC Item | 43598051101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 43598051163
| NDC 9 | 43598-511 |
|---|---|
| NDC 10 | 43598-511-63 |
| NDC Item | 43598051163 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;5;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 43598-511 |
NDC Item 47781048401
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-01 |
| NDC Item | 47781048401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 47781048428
| NDC 9 | 47781-484 |
|---|---|
| NDC 10 | 47781-484-28 |
| NDC Item | 47781048428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
| ANDA | ANDA210480 |
| COLORTEXT | GREEN,YELLOW(light caramel) |
| Color | C48329;C48330 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;638 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 47781-484 |
NDC Item 59651034301
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-01 |
| NDC Item | 59651034301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034307
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-07 |
| NDC Item | 59651034307 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 59651034328
| NDC 9 | 59651-343 |
|---|---|
| NDC 10 | 59651-343-28 |
| NDC Item | 59651034328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;5 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59651-343 |
NDC Item 60505453301
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-1 |
| NDC Item | 60505453301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 60505453302
| NDC 9 | 60505-4533 |
|---|---|
| NDC 10 | 60505-4533-2 |
| NDC Item | 60505453302 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L5 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4533 |
NDC Item 63304004201
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-01 |
| NDC Item | 63304004201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 63304004227
| NDC 9 | 63304-042 |
|---|---|
| NDC 10 | 63304-042-27 |
| NDC Item | 63304004227 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
| ANDA | ANDA211846 |
| COLORTEXT | WHITE,WHITE |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;79 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 63304-042 |
NDC Item 69097038173
| NDC 9 | 69097-381 |
|---|---|
| NDC 10 | 69097-381-73 |
| NDC Item | 69097038173 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla5mg;381 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69097-381 |
NDC Item 70710103101
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-1 |
| NDC Item | 70710103101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70710103107
| NDC 9 | 70710-1031 |
|---|---|
| NDC 10 | 70710-1031-7 |
| NDC Item | 70710103107 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1031 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70710-1031 |
NDC Item 70771167701
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-1 |
| NDC Item | 70771167701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 70771167707
| NDC 9 | 70771-1677 |
|---|---|
| NDC 10 | 70771-1677-7 |
| NDC Item | 70771167707 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap with white opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1031 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70771-1677 |
NDC Item 76282069748
| NDC 9 | 76282-697 |
|---|---|
| NDC 10 | 76282-697-48 |
| NDC Item | 76282069748 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(printed in black-ink) |
| Color | C48325 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla5mg;381 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 76282-697 |